How are IDXX straddle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the IDXX straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 32.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$3,892.08 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a IDXX straddle?

The breakeven for the IDXX straddle priced on this page is roughly $488.60 and $571.40 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IDXX market-implied 1-standard-deviation expected move is approximately 9.26%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current IDXX implied volatility affect this straddle?

IDXX ATM IV is at 32.30% with IV rank near 29.08%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

IDXX Straddle Strategy

IDXX (IDEXX Laboratories, Inc.), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NASDAQ.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers.

IDXX (IDEXX Laboratories, Inc.) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $41.70B, a trailing P/E of 38.66, a beta of 1.57 versus the broader market, a 52-week range of 496.61-769.98, average daily share volume of 540K, a public-listing history dating back to 1991, approximately 11K full-time employees. These structural characteristics shape how IDXX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.57 indicates IDXX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. The trailing P/E of 38.66 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.

What is a straddle on IDXX?

A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.

Current IDXX snapshot

As of May 15, 2026, spot at $530.18, ATM IV 32.30%, IV rank 29.08%, expected move 9.26%. The straddle on IDXX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this straddle structure on IDXX specifically: IDXX IV at 32.30% is on the cheap side of its 1-year range, which favors premium-buying structures like a IDXX straddle, with a market-implied 1-standard-deviation move of approximately 9.26% (roughly $49.10 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IDXX expiries trade a higher absolute premium for lower per-day decay. Position sizing on IDXX should anchor to the underlying notional of $530.18 per share and to the trader's directional view on IDXX stock.

IDXX straddle setup

The IDXX straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IDXX near $530.18, the first option leg uses a $530.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IDXX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IDXX shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$530.00	$21.70
Buy 1	Put	$530.00	$19.70

IDXX straddle risk and reward

Net Premium / Debit: -$4,140.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$3,892.08
Breakeven(s): $488.60, $571.40
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.

IDXX straddle payoff curve

Modeled P&L at expiration across a range of underlying prices for the straddle on IDXX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$48,859.00
$117.23	-77.9%	+$37,136.54
$234.46	-55.8%	+$25,414.08
$351.68	-33.7%	+$13,691.61
$468.91	-11.6%	+$1,969.15
$586.13	+10.6%	+$1,473.31
$703.36	+32.7%	+$13,195.77
$820.58	+54.8%	+$24,918.24
$937.81	+76.9%	+$36,640.70
$1,055.03	+99.0%	+$48,363.16

When traders use straddle on IDXX

Straddles on IDXX are pure-volatility plays that profit from large moves in either direction; traders typically buy IDXX straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.

IDXX thesis for this straddle

The market-implied 1-standard-deviation range for IDXX extends from approximately $481.08 on the downside to $579.28 on the upside. A IDXX long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current IDXX IV rank near 29.08% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on IDXX at 32.30%. As a Healthcare name, IDXX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IDXX-specific events.

IDXX straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IDXX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IDXX alongside the broader basket even when IDXX-specific fundamentals are unchanged. Always rebuild the position from current IDXX chain quotes before placing a trade.

Frequently asked questions

What is a straddle on IDXX?: A straddle on IDXX is the straddle strategy applied to IDXX (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With IDXX stock trading near $530.18, the strikes shown on this page are snapped to the nearest listed IDXX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are IDXX straddle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the IDXX straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 32.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$3,892.08 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a IDXX straddle?: The breakeven for the IDXX straddle priced on this page is roughly $488.60 and $571.40 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IDXX market-implied 1-standard-deviation expected move is approximately 9.26%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a straddle on IDXX?: Straddles on IDXX are pure-volatility plays that profit from large moves in either direction; traders typically buy IDXX straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
How does current IDXX implied volatility affect this straddle?: IDXX ATM IV is at 32.30% with IV rank near 29.08%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.